MARSHALL WACE, LLP - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 55 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2022$173,000
-46.1%
152,671
-29.9%
0.00%
-100.0%
Q2 2022$321,000
-66.0%
217,815
-47.1%
0.00%
-50.0%
Q1 2022$943,000
+193.8%
412,031
+670.5%
0.00%
+100.0%
Q3 2021$321,000
-71.4%
53,474
-76.8%
0.00%
-80.0%
Q2 2021$1,122,000
+36.0%
230,441
-31.0%
0.01%
+25.0%
Q1 2021$825,000
-79.5%
334,108
-25.7%
0.00%
-84.6%
Q4 2016$4,021,000
+44.8%
449,820
+181.1%
0.03%
+30.0%
Q3 2016$2,776,000
+147.4%
160,0000.0%0.02%
+122.2%
Q2 2016$1,122,000160,0000.01%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders